The FDA has rejected a nasal spray that would have been the first alternative to injections for treating severe allergic reactions. The agency is calling for more research on repeat doses of the drug epinephrine, which is used to halt anaphylaxis, a potentially life-threatening allergic reaction.
Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issues
September 23, 2023.png)
.png)
.png)
